microRNA-214-mediated UBC9 expression in glioma
![]() |
Zhao, Zhiqiang
(The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College)
Tan, Xiaochao (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) Zhao, Ani (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) Zhu, Liyuan (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) Yin, Bin (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) Yuan, Jiangang (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) Qiang, Boqin (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) Peng, Xiaozhong (The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College) |
1 | Johnson, E. S. (2004) Protein modification by SUMO. Ann. Rev. Biochem. 73, 355-382. DOI ScienceOn |
2 | Verger, A., Perdomo, J. and Crossley, M. (2003) Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4, 137-142. DOI ScienceOn |
3 | Kerscher, O., Felberbaum, R. and Hochstrasser, M. (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22, 159-180. DOI ScienceOn |
4 | Capili, A. D. and Lima, C. D. (2007) Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways. Curr. Opin. Struct. Biol. 17, 726-735. DOI ScienceOn |
5 | Geiss-Friedlander, R. and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. 8, 947-956. DOI ScienceOn |
6 | Bernier-Villamor, V., Sampson, D. A., Matunis, M. J. and Lima, C. D. (2002) Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108, 345-356. DOI ScienceOn |
7 | Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M. and Del Sal, G. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462-6471. DOI ScienceOn |
8 | Mo, Y. Y., Yu, Y., Theodosiou, E., Ee, P. L. and Beck, W. T. (2005) A role for Ubc9 in tumorigenesis. Oncogene 24, 2677-2683. DOI ScienceOn |
9 | Zhu, S., Sachdeva, M., Wu, F., Lu, Z. and Mo, Y. Y. (2010) Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 29, 1763-1772. DOI ScienceOn |
10 | Moschos, S. J., Jukic, D. M., Athanassiou, C., Bhargava, R., Dacic, S., Wang, X., Kuan, S. F., Fayewicz, S. L., Galambos, C., Acquafondata, M., Dhir, R. and Becker, D. (2010) Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Hum. Pathol. 41, 1286-1298. DOI ScienceOn |
11 | Wu, F., Zhu, S., Ding, Y., Beck, W. T. and Mo, Y. Y. (2009) MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin. Cancer Res. 15, 1550-1557. DOI ScienceOn |
12 | Yu, F., Deng, H., Yao, H., Liu, Q., Su, F. and Song, E. (2010) Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29, 4194-4204. DOI ScienceOn |
13 | Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. DOI ScienceOn |
14 | Esquela-Kerscher, A. and Slack, F. J. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269. DOI ScienceOn |
15 | van Jaarsveld, M. T., Helleman, J., Berns, E. M. and Wiemer, E. A. (2010) MicroRNAs in ovarian cancer biology and therapy resistance. Int. J. Biochem. Cell Biol. 42, 1282-1290. DOI ScienceOn |
16 | Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., Chin, L., DePinho, R. A. and Cavenee, W. K. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21, 2683-2710. DOI ScienceOn |
17 | Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F. and Croce C. M. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99,15524-15529. DOI ScienceOn |
18 | Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., Iuliano, R., Palumbo, T., Pichiorri, F., Roldo, C., Garzon, R., Sevignani, C., Rassenti, L., Alder, H., Volinia, S., Liu, C. G., Kipps, T. J., Negrini, M. and Croce, C. M. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New Engl. J. Med. 353, 1793-1801. DOI ScienceOn |
19 | Tombol, Z., Szabo, P. M., Molnar, V., Wiener, Z., Tolgyesi, G., Horanyi, J., Riesz, P., Reismann, P., Patocs, A., Liko, I., Gaillard, R. C., Falus, A., Racz, K. and Igaz, P. (2009) Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr. Relat. Cancer 16, 895-906. DOI ScienceOn |
20 | Yang, H., Kong, W., He, L., Zhao, J. J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V. and Cheng, J. Q. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433. DOI ScienceOn |
21 | Derfoul, A., Juan, A. H., Difilippantonio, M. J., Palanisamy, N., Ried, T. and Sartorelli, V. (2011) Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis 32, 1607-1614. DOI ScienceOn |
22 | Magrelli, A., Azzalin, G., Salvatore, M., Viganotti, M., Tosto, F., Colombo, T., Devito, R., Di Masi, A., Antoccia, A., Lorenzetti, S., Maranghi, F., Mantovani, A., Tanzarella, C., Macino, G. and Taruscio, D. (2009) Altered microRNA Expression Patterns in Hepatoblastoma Patients. Translat. Oncol. 2, 157-163. DOI |
23 | Qiang, R., Wang, F., Shi, L. Y., Liu, M., Chen, S., Wan, H. Y., Li, Y. X., Li, X., Gao, S. Y., Sun, B. C. and Tang, H. (2011) Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int. J. Biochem. Cell Biol. 43, 632-41. DOI ScienceOn |
24 | Lee, Y. B., Bantounas, I., Lee, D. Y., Phylactou, L., Caldwell, M. A. and Uney, J. B. (2009) Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res. 37, 123-128. DOI ScienceOn |
25 | Chen, Y., Liu, W., Chao, T., Zhang, Y., Yan, X., Gong, Y., Qiang, B., Yuan, J., Sun, M. and Peng, X. (2008) MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett. 272, 197-205. DOI ScienceOn |
26 | Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., Barbisin, M., Xu, N. L., Mahuvakar, V. R., Andersen, M. R., Lao, K. Q., Livak, K. J. and Guegler, K. J. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179. DOI ScienceOn |
27 | Zhang, Y., Chao, T., Li, R., Liu, W., Chen, Y., Yan, X., Gong, Y., Yin, B., Qiang, B., Zhao, J., Yuan, J. and Peng, X. (2008) MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Mol. Med. 87, 43-51. |
![]() |